Repligen Corp
(NAS:RGEN)
$
168.71
-3.07 (-1.79%)
Market Cap: 9.43 Bil
Enterprise Value: 9.54 Bil
PE Ratio: 674.84
PB Ratio: 4.78
GF Score: 93/100 Repligen Corp at Stifel Healthcare Conference (Virtual) Transcript
Nov 17, 2021 / 01:00PM GMT
Release Date Price:
$277.48
(+3.16%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Welcome back, everyone. This is Day 3 of the Stifel Healthcare Conference, and we are on the life sciences and diagnostics track. And with us, to kick things off this morning, is Repligen. We have CEO, Tony Hunt; and CFO, Jon Snodgres, with us. Guys, thanks a bunch for joining us today and spending some time talking.
Anthony J. Hunt
Repligen Corporation - CEO, President & Director
Great. Good to be here, Dan.
Questions & Answers
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Yes. So Tony, we've taken a bit of a step backwards since June when we got together, and it felt like the virtual stuff was winding down, but we're -- it's okay. We're getting there. Hopefully, we get there soon anyway. And during that time, the business continues to perform well. 2021 is going to be another good year for you guys.
So can
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot